Valuation Sanofi

Stocks

Market Closed - Euronext Paris 19:55:00 13/10/2026 +04			5-day change	1st Jan Change
70.74 ^EUR	-1.20%		+0.18%	-14.48%

10-13	Nurix Therapeutics' Enterprise Value Remains Underappreciated, RBC Capital Markets Says	MT
10-07	Pharmaceutical Group Sues US Government Over Medicare Drug Pricing Rule	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	111,194	112,665	112,549	116,968	100,655	84,751	-	-
Change	-	1.32%	-0.1%	3.93%	-13.95%	-15.8%	-	-
Enterprise Value (EV) ¹	121,177	119,102	120,342	125,740	111,663	96,087	92,755	89,924
Change	-	-1.71%	1.04%	4.49%	-11.2%	-13.95%	-3.47%	-3.05%
P/E	17.8x	16.7x	20.8x	20.4x	12.9x	11.5x	9.9x	8.52x
PBR	1.62x	1.5x	1.52x	1.51x	1.41x	1.15x	1.08x	1.02x
PEG	-	2.07x	-1.1x	3.14x	0.3x	-2.98x	0.6x	0.5x
Capitalization / Revenue	2.94x	2.62x	2.61x	2.85x	2.31x	1.79x	1.68x	1.59x
EV / Revenue	3.21x	2.77x	2.79x	3.06x	2.56x	2.03x	1.84x	1.69x
EV / EBITDA	9.95x	8.14x	8.44x	9.76x	8.22x	6.49x	5.89x	5.26x
EV / EBIT	11.3x	9.13x	9.5x	11.1x	9.19x	7.29x	6.72x	5.97x
EV / FCF	15x	14x	14.2x	21.1x	13.8x	11.7x	10.3x	8.97x
FCF Yield	6.68%	7.12%	7.04%	4.74%	7.24%	8.56%	9.69%	11.1%
Dividend per Share ²	3.33	3.56	3.76	3.92	4.12	4.256	4.502	4.801
Rate of return	3.76%	3.96%	4.19%	4.18%	4.98%	6.02%	6.36%	6.79%
EPS ²	4.97	5.37	4.31	4.59	6.4	6.153	7.144	8.3
Distribution rate	67%	66.3%	87.2%	85.4%	64.4%	69.2%	63%	57.8%
Net sales ¹	37,761	42,997	43,070	41,081	43,626	47,373	50,474	53,227
EBITDA ¹	12,183	14,627	14,259	12,889	13,583	14,795	15,744	17,112
EBIT ¹	10,714	13,040	12,670	11,343	12,149	13,172	13,806	15,054
Net income ¹	6,223	6,720	5,400	5,744	7,813	7,298	8,814	10,260
Net Debt ¹	9,983	6,437	7,793	8,772	11,008	11,336	8,004	5,173
Reference price ²	88.58	89.84	89.76	93.74	82.72	70.74	70.74	70.74
Nbr of stocks (in thousands)	1,255,293	1,254,060	1,253,891	1,247,793	1,216,810	1,198,069	-	-
Announcement Date	04/02/22	03/02/23	01/02/24	30/01/25	29/01/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SANOFI	11.64x	2.05x	6.57x	5.94%	95.82B
ELI LILLY AND COMPANY	33.65x	12.2x	25.64x	0.58%	1,054B
JOHNSON & JOHNSON	29.26x	6.48x	18.46x	2.02%	636B
ABBVIE INC.	35.78x	8.25x	17.01x	2.47%	497B
MERCK & CO., INC.	111.13x	5.93x	25.32x	2.35%	359B
ROCHE HOLDING AG	19.43x	4.75x	11.8x	2.78%	345B
NOVARTIS AG	20.12x	5.29x	13.01x	3.01%	273B
ASTRAZENECA PLC	20.57x	4.22x	12.08x	2.1%	246B
AMGEN INC.	26.51x	6.86x	12.28x	2.42%	226B
GILEAD SCIENCES, INC.	-45.64x	6.72x	26.17x	2.19%	187B
Average	26.24x	6.27x	16.83x	2.59%	391.8B
Weighted average by Cap.	32.56x	7.74x	19.19x	1.99%